Company: SXTPW
Filing Date: 2025-06-06
Form Type: DRS
Source: 0001213900-25-052232
Chunk: 43

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-06-06
Form: DRS
Chunk 43
---
 return to our stockholders. If we do not invest or apply the
net proceeds from this offering in ways that enhance stockholder value, we may fail to achieve expected financial results, which could
cause our stock price to decline.

Investors in this offering may experience future dilution as a result of this and future equity offerings.

In order to raise additional capital, we may in
the future offer additional shares of our common stock or other securities convertible into or exchangeable for our common stock. Investors
purchasing our shares or other securities in the future could have rights superior to existing common stockholders, and the price per
share at which we sell additional shares of our common stock or other securities convertible into or exchangeable for our common stock
in future transactions may be higher or lower than the price per share in this offering.

<div align='center'>21</div>

The issuance of shares upon exercise of derivative securities may cause immediate and substantial dilution to our existing stockholders.

The issuance of shares upon exercise of options or warrants and settlement
of any outstanding restricted stock units may result in substantial dilution to the interests of other stockholders since these selling
stockholders may ultimately convert or exercise and sell all or a portion of the full amount issuable upon exercise. If all derivative
securities outstanding as of , 2025 were converted or exercised into shares of common stock, there would be an additional shares of common
stock outstanding as a result. The issuance of these shares will have the effect of further diluting the proportionate equity interest
and voting power of holders of our common stock.

The price of our common stock may be volatile, and you may be unable to resell your shares at or above the offering price.

The trading price of our common stock following
this offering may fluctuate substantially. Following the closing of this public offering, the market price of our common stock may be
higher or lower than the price you pay in the offering, depending on many factors, some of which are beyond our control and may not be
related to our operating performance. These fluctuations could cause you to lose all or part of your investment in our common stock. Factors
that could cause fluctuations in the trading price of our common stock include the following:

| ● | limited trading volume; |

| ● | actual or anticipated fluctuations in our financial condition and operating results; |

| ● | actual or anticipated changes in our growth rate relative to our competitors; |

| ● | commercial success and market acceptance of our product; |

|